loading
Atai Life Sciences N V stock is traded at $4.57, with a volume of 8.91M. It is up +4.10% in the last 24 hours and up +29.46% over the past month. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
See More
Previous Close:
$4.39
Open:
$4.48
24h Volume:
8.91M
Relative Volume:
1.70
Market Cap:
$915.54M
Revenue:
$314.00K
Net Income/Loss:
$-40.23M
P/E Ratio:
-16.32
EPS:
-0.28
Net Cash Flow:
$-84.71M
1W Performance:
+17.78%
1M Performance:
+29.46%
6M Performance:
+129.65%
1Y Performance:
+254.26%
1-Day Range:
Value
$4.36
$4.74
1-Week Range:
Value
$3.76
$4.74
52-Week Range:
Value
$1.03
$4.74

Atai Life Sciences N V Stock (ATAI) Company Profile

Name
Name
Atai Life Sciences N V
Name
Phone
49 89 2153 9035
Name
Address
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Name
Employee
54
Name
Twitter
Name
Next Earnings Date
2024-12-11
Name
Latest SEC Filings
Name
ATAI's Discussions on Twitter

Compare ATAI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ATAI
Atai Life Sciences N V
4.57 868.07M 314.00K -40.23M -84.71M -0.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-29-25 Initiated Oppenheimer Outperform
Nov-18-24 Reiterated H.C. Wainwright Buy
Apr-03-24 Upgrade Maxim Group Hold → Buy
Nov-01-22 Initiated Loop Capital Buy
Nov-30-21 Initiated Maxim Group Buy
Nov-11-21 Initiated ROTH Capital Buy
Oct-18-21 Initiated H.C. Wainwright Buy
Sep-01-21 Initiated Jefferies Buy
Jul-13-21 Initiated Berenberg Buy
Jul-13-21 Initiated Canaccord Genuity Buy
Jul-13-21 Initiated Cantor Fitzgerald Buy
Jul-13-21 Initiated Citigroup Buy
Jul-13-21 Initiated Cowen Outperform
Jul-13-21 Initiated Credit Suisse Outperform
Jul-13-21 Initiated RBC Capital Mkts Sector Perform
Jul-08-21 Initiated Aegis Capital Buy
View All

Atai Life Sciences N V Stock (ATAI) Latest News

pulisher
Aug 18, 2025

Apeiron Investment Group Buys 8.7M Shares in ATAI Life Sciences at $2.19/Share - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

Here's Why atai Life Sciences (ATAI) Is a Great 'Buy the Bottom' Stock Now - Zacks Investment Research

Aug 18, 2025
pulisher
Aug 18, 2025

What are Atai Life Sciences N.V.’s recent SEC filings showingTrade Entry Report & Low Risk Entry Point Guides - 선데이타임즈

Aug 18, 2025
pulisher
Aug 17, 2025

Institutional Tools Highlight Unusual Flow in Atai Life Sciences N.V.Market Growth Review & Technical Confirmation Alerts - theviewers.co.kr

Aug 17, 2025
pulisher
Aug 15, 2025

Atai Life Sciences shares rise 1.50% premarket after reporting Q2 earnings results. - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Atai Life Sciences N.V. Nearing Breakout Level After BounceEarnings Miss & Daily Growth Stock Investment Tips - metal.it

Aug 15, 2025
pulisher
Aug 15, 2025

Is Atai Life Sciences N.V. the Top Chart Pick This Week2025 Stock Rankings & AI Powered Market Entry Strategies - beatles.ru

Aug 15, 2025
pulisher
Aug 15, 2025

Atai Life Sciences Reports Q2 2025 Financial Results - TipRanks

Aug 15, 2025
pulisher
Aug 14, 2025

Atai Life Sciences shares fall 1.50% after-hours following earnings report. - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Atai Life Sciences N.V. Facing Inflection Point in Trend AnalysisVolume Spike & Safe Investment Capital Preservation Plans - newsyoung.net

Aug 14, 2025
pulisher
Aug 14, 2025

Atai Life Sciences Revenue Jumps 163% - The Motley Fool

Aug 14, 2025
pulisher
Aug 14, 2025

atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates - TradingView

Aug 14, 2025
pulisher
Aug 14, 2025

Earnings Flash (ATAI) ATAI Life Sciences N.V. Reports Q2 Revenue $719,000 - MarketScreener

Aug 14, 2025
pulisher
Aug 14, 2025

Earnings Flash (ATAI) Atai Life Sciences Posts Q2 Net Loss $0.14 a Share, vs. FactSet Est of $0.11 Loss - MarketScreener

Aug 14, 2025
pulisher
Aug 04, 2025

Atai Life Sciences N.V. Bounces Off Moving Average SupportConservative Long Term Growth Plans Under Review - metal.it

Aug 04, 2025
pulisher
Aug 04, 2025

Maxim Group Reiterates a Buy Rating on Atai Life Sciences (ATAI) With a $10 PT - Insider Monkey

Aug 04, 2025
pulisher
Aug 03, 2025

How volatile is Atai Life Sciences N.V. stock compared to the marketAchieve consistent profits with expert advice - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Atai Life Sciences N.V. Stock Analysis and ForecastFree Stock Market Return Analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Atai Life Sciences N.V. in the next 12 monthsBoost your returns with professional guidance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How many analysts rate Atai Life Sciences N.V. as a “Buy”Dynamic profit expansion - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for Atai Life Sciences N.V.Maximize your gains with professional insights - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives Atai Life Sciences N.V. stock priceGet timely advice on market trends - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does Atai Life Sciences N.V. stock perform well during market downturnsTrack top-performing stocks effortlessly - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

How does Atai Life Sciences N.V. generate profit in a changing economyFree Trend-Following Techniques - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What is the risk reward ratio of investing in Atai Life Sciences N.V. stockDiscover breakthrough stocks with expert help - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 02, 2025

How does Atai Life Sciences N.V. compare to its industry peersSky-high return potential - Jammu Links News

Aug 02, 2025
pulisher
Jul 31, 2025

H.C. Wainwright Lifts PT on Atai Life Sciences (ATAI) to $15 From $10 - Insider Monkey

Jul 31, 2025
pulisher
Jul 31, 2025

AbbVie in Talks to Acquire Gilgamesh in $1 Billion Deal - Bloomberg.com

Jul 31, 2025
pulisher
Jul 31, 2025

H.C. Wainwright raises atai Life Sciences stock price target to $15 on BPL-003 potential - Investing.com Nigeria

Jul 31, 2025
pulisher
Jul 30, 2025

This IonQ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Jul 30, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-30 03:07:04 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

What makes Atai Life Sciences N.V. stock price move sharplySwing Setup With Technical Confirmation Explained - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

This Atai Life Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday - 富途牛牛

Jul 29, 2025
pulisher
Jul 29, 2025

How did ATAI's revenue and expenses shift in Q4 2024? - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Oppenheimer initiates coverage on ATAI Life Sciences with Outperform rating, $14 PT. - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Oppenheimer initiates atai Life Sciences stock with Outperform rating By Investing.com - Investing.com Nigeria

Jul 29, 2025
pulisher
Jul 29, 2025

Oppenheimer initiates atai Life Sciences stock with Outperform rating - Investing.com

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 09:29:36 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Oppenheimer Initiates ATAI Life Sciences N.V at Outperform With $14 Price Target - MarketScreener

Jul 29, 2025
pulisher
Jul 28, 2025

Atai: Inidascamine Trial Failure Doesn't Matter In Main Psychedelic Pipeline Focus (ATAI) - Seeking Alpha

Jul 28, 2025
pulisher
Jul 28, 2025

ATAI Life Sciences Surges Amidst Market Uncertainty - StocksToTrade

Jul 28, 2025
pulisher
Jul 28, 2025

Why Is ATAI Life Sciences Stock Trading Lower On Monday? - inkl

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 17:17:36 - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

ATAI Life Sciences (ATAI) Stock Plunge on Trial Failure News - Yahoo Finance

Jul 28, 2025
pulisher
Jul 28, 2025

ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session - 富途牛牛

Jul 28, 2025
pulisher
Jul 28, 2025

Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Jul 28, 2025
pulisher
Jul 28, 2025

Nucor, Waste Management And 3 Stocks To Watch Heading Into Monday - Benzinga

Jul 28, 2025
pulisher
Jul 28, 2025

What is Atai Life Sciences N.V. company’s growth strategyGet insider insights into market trends - Jammu Links News

Jul 28, 2025
pulisher
Jul 27, 2025

What are Atai Life Sciences N.V. company’s key revenue driversExceptional stock performance - Jammu Links News

Jul 27, 2025
pulisher
Jul 27, 2025

Why Atai Life Sciences N.V. stock attracts strong analyst attentionFree Access to Community - metal.it

Jul 27, 2025
pulisher
Jul 26, 2025

Atai Life Sciences (ATAI) Shares Drop 12% After Schizophrenia Dr - GuruFocus

Jul 26, 2025

Atai Life Sciences N V Stock (ATAI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):